Lexicon Pharmaceuticals
LXRX
#6241
Rank
โ‚น96.71 B
Marketcap
โ‚น217.72
Share price
-1.95%
Change (1 day)
108.19%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -โ‚น6.29

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น6.76. In 2025 the company made an earnings per share (EPS) of -โ‚น13.52 an increase over its 2024 EPS that were of -โ‚น61.79.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น6.29-53.49%
2025-โ‚น13.52-78.13%
2024-โ‚น61.79-20%
2023-โ‚น77.2431.15%
2022-โ‚น58.90-0%
2021-โ‚น58.9010.91%
2020-โ‚น53.10-145.08%
2019โ‚น117.79-206.09%
2018-โ‚น111.03-5.74%
2017-โ‚น117.79-10.95%
2016-โ‚น132.282640%
2015-โ‚น4.83-96.34%
2014-โ‚น131.75-2.53%
2013-โ‚น135.17-9.09%
2012-โ‚น148.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,759-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น533.93-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,106-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น589.93 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น756.97-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.93-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น72.41 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น135.17-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1,58,031 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA